175 related articles for article (PubMed ID: 10521053)
21. Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women.
Cui Y; Deming-Halverson SL; Shrubsole MJ; Beeghly-Fadiel A; Fair AM; Sanderson M; Shu XO; Kelley MC; Zheng W
Clin Breast Cancer; 2014 Dec; 14(6):417-25. PubMed ID: 24970715
[TBL] [Abstract][Full Text] [Related]
22. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004.
Brown M; Tsodikov A; Bauer KR; Parise CA; Caggiano V
Cancer; 2008 Feb; 112(4):737-47. PubMed ID: 18189290
[TBL] [Abstract][Full Text] [Related]
23. Associations of dietary folate, Vitamins B6 and B12 and methionine intake with risk of breast cancer among African American and European American women.
Gong Z; Ambrosone CB; McCann SE; Zirpoli G; Chandran U; Hong CC; Bovbjerg DH; Jandorf L; Ciupak G; Pawlish K; Lu Q; Hwang H; Khoury T; Wiam B; Bandera EV
Int J Cancer; 2014 Mar; 134(6):1422-35. PubMed ID: 23996837
[TBL] [Abstract][Full Text] [Related]
24. Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.
Sparano JA; Wang M; Zhao F; Stearns V; Martino S; Ligibel JA; Perez EA; Saphner T; Wolff AC; Sledge GW; Wood WC; Davidson NE
J Natl Cancer Inst; 2012 Mar; 104(5):406-14. PubMed ID: 22250182
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of clinicopathological characteristics and prognosis for triple negative breast cancer: a report of 108 cases].
Guan Y; Xu BH
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):196-9. PubMed ID: 18756935
[TBL] [Abstract][Full Text] [Related]
26. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
Killelea BK; Yang VQ; Wang SY; Hayse B; Mougalian S; Horowitz NR; Chagpar AB; Pusztai L; Lannin DR
J Clin Oncol; 2015 Dec; 33(36):4267-76. PubMed ID: 26598753
[TBL] [Abstract][Full Text] [Related]
27. Examination of ancestral informative markers and self-reported race with tumor characteristics of breast cancer among Black and White women.
Reding KW; Carlson CS; Kahsai O; Chen CC; McDavid A; Doody DR; Chen C; Ornelas I; Lowe K; Bernstein L; Weiss L; McDonald JA; Simon MS; Strom B; Marchbanks PA; Burkman R; Spirtas R; Liff JM; Malone KE
Breast Cancer Res Treat; 2012 Jul; 134(2):801-9. PubMed ID: 22648732
[TBL] [Abstract][Full Text] [Related]
28. Breast carcinoma survival analysis for African American and white women in an equal-access health care system.
Wojcik BE; Spinks MK; Optenberg SA
Cancer; 1998 Apr; 82(7):1310-8. PubMed ID: 9529023
[TBL] [Abstract][Full Text] [Related]
29. High prevalence of triple-negative tumors in an urban cancer center.
Lund MJ; Butler EN; Bumpers HL; Okoli J; Rizzo M; Hatchett N; Green VL; Brawley OW; Oprea-Ilies GM; Gabram SG
Cancer; 2008 Aug; 113(3):608-15. PubMed ID: 18484596
[TBL] [Abstract][Full Text] [Related]
30. Hormone receptors in breast cancer: racial differences in distribution and survival.
Joslyn SA
Breast Cancer Res Treat; 2002 May; 73(1):45-59. PubMed ID: 12083631
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with axillary lymph node metastasis from breast carcinoma: descriptive and predictive analyses.
Gann PH; Colilla SA; Gapstur SM; Winchester DJ; Winchester DP
Cancer; 1999 Oct; 86(8):1511-9. PubMed ID: 10526280
[TBL] [Abstract][Full Text] [Related]
32. Race is a fundamental prognostic indicator for 2325 northeastern Ohio women with infiltrating breast cancer.
Crowe JP; Patrick RJ; Rybicki LA; Grundfest-Broniatowski S; Kim JA; Lee KB
Breast J; 2005; 11(2):124-8. PubMed ID: 15730458
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.
Ferguson NL; Bell J; Heidel R; Lee S; Vanmeter S; Duncan L; Munsey B; Panella T; Orucevic A
Breast J; 2013; 19(1):22-30. PubMed ID: 23240985
[TBL] [Abstract][Full Text] [Related]
34. Racial differences in CD8
Abdou Y; Attwood K; Cheng TD; Yao S; Bandera EV; Zirpoli GR; Ondracek RP; Stein L; Bshara W; Khoury T; Ambrosone CB; Omilian AR
Breast Cancer Res; 2020 Jun; 22(1):62. PubMed ID: 32517730
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of bcl-2 expression among women with breast cancer in Libya.
Ermiah E; Buhmeida A; Khaled BR; Abdalla F; Salem N; Pyrhönen S; Collan Y
Tumour Biol; 2013 Jun; 34(3):1569-78. PubMed ID: 23417836
[TBL] [Abstract][Full Text] [Related]
36. Triple-negative breast cancers: a view from 10,000 feet.
Ray M; Polite BN
Cancer J; 2010; 16(1):17-22. PubMed ID: 20164686
[TBL] [Abstract][Full Text] [Related]
37. Age-related differences in breast cancer stage at diagnosis between black and white patients in an urban community hospital.
Newman LA; Alfonso AE
Ann Surg Oncol; 1997 Dec; 4(8):655-62. PubMed ID: 9416414
[TBL] [Abstract][Full Text] [Related]
38. Race, socioeconomic status, and breast carcinoma in the U.S: what have we learned from clinical studies.
Cross CK; Harris J; Recht A
Cancer; 2002 Nov; 95(9):1988-99. PubMed ID: 12404294
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of HER-2/NEU receptor of invasive mammary carcinoma between Caucasian and African American patients in the Detroit metropolitan area. Correlation with overall survival and other prognostic factors.
Al-Abbadi MA; Washington TA; Saleh HA; Tekyi-Mensah SE; Lucas DR; Briston CA
Breast Cancer Res Treat; 2006 May; 97(1):3-8. PubMed ID: 16432664
[TBL] [Abstract][Full Text] [Related]
40. Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study.
O'Brien KM; Cole SR; Tse CK; Perou CM; Carey LA; Foulkes WD; Dressler LG; Geradts J; Millikan RC
Clin Cancer Res; 2010 Dec; 16(24):6100-10. PubMed ID: 21169259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
